Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Indo Straits Tbk. (PTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Indo Straits Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Indo Straits Tbk. trades at Rp260 (market cap 144.14B, 66.9K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 66.9K). Which is the better fit depends on your goals.
| OBAT | PTIS | |
|---|---|---|
Market Cap | 166.01B | 144.14B |
Volume | 324K | 66.9K |
Lot | 3.24K | 669 |
Turnover | 77.68M | 17.5M |
Average Price | 239.75 | 261.64 |
Value | 77.68M | 17.5M |
Indicative Equilibrium Price | 240 | 260 |
Indicative Equilibrium Volume | 1 | 20 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Indo Straits Tbk.
PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Read more on PTIS →
